Navigation Links
MedQuist Announces Completion of Spheris Transaction
Date:4/23/2010

atisfaction are continued in a seamless manner, supporting their customers' patient care mission.

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors – help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

MedQuist offers an industry-leading healthcare information management platform (DocQment Enterprise Platform®), which serves as the foundation for its transcription service offerings and includes workflow management, core measures reporting, structured documentation, data analytics, and key customer reporting.  In addition, MedQuist solutions include SpeechQ™ real-time interactive speech recognition for radiology and general medicine, DocQvoice™ for capturing dictation, and computer-assisted coding and abstracting.  This blend of solutions drives document quality and accuracy and advances the adoption of electronic health records -- resulting in improved patient care and higher levels of efficiency.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual o
'/>"/>

SOURCE MedQuist Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedQuist Reports First Quarter 2008 Results
2. MedQuist and StructuRad Form Partnership to Integrate Report Macros into SpeechQ for Radiology(TM)
3. MedQuist Announces Additions to Board of Directors
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/19/2014)... Piscataway, NJ (PRWEB) August 20, 2014 ... engineering and regenerative medicine is an inadequate vascular ... engineered constructs and decellularized tissues is critical for ... Researchers have attempted to mitigate deficiencies in vascularization ... including adding scaffold bioactivity, optimizing scaffold design and ...
(Date:8/19/2014)... Calif. (PRWEB) August 19, 2014 ... campaign to raise $200,000 to fund a corporate ... device. , This development is a critical ... model of care to the implementation of personalized ... method of practicing medicine. , Indiegogo contributions will ...
(Date:8/19/2014)... 19, 2014 Research and ... the "Spectroscopy Equipment and Accessories - ... their offering. This report ... and Accessories in US$ Thousands by the ... Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) ...
Breaking Biology Technology:Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2
... , , SEATTLE, Aug. 11 ... 2 clinical trial of OMS302, the Company,s ophthalmologic PharmacoSurgery(TM) ... anti-inflammatory agent and an agent that causes pupil dilation ... , Omeros, Phase 1/Phase 2 trial ...
... , , SEATTLE, Aug. 11 ... quarter ended June 30, 2009. Revenue for the second quarter of 2009 ... Revenue for the six months ended June 30, 2009 was $55,000 compared to ... Dendreon,s total operating expenses for the second quarter of 2009 were ...
... Diverse Student ... , ... 11, 2009 - As a new class of eager high school seniors begins the college ... mark, a new study reveals what Americans consider to be the defining characteristics of a ...
Cached Biology Technology:Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery 2Dendreon Reports Second Quarter 2009 Financial Results 2Dendreon Reports Second Quarter 2009 Financial Results 3Dendreon Reports Second Quarter 2009 Financial Results 4Dendreon Reports Second Quarter 2009 Financial Results 5Dendreon Reports Second Quarter 2009 Financial Results 6What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate 2What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate 3What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate 4What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate 5
(Date:8/19/2014)... devised a new implantable tissue scaffold coated with bone ... weeks. When applied to bone injuries or defects, this ... bone that looks and behaves just like the original ... a dramatic improvement over the current standard for treating ... of the patient,s body a painful process that ...
(Date:8/19/2014)... infants born with neonatal abstinence syndrome (NAS) secondary ... time going through withdrawal than others, but the ... and epigenetic (when genes are turned on or ... factors, researchers at Boston University School of Medicine ... first of its kind study to identify some ...
(Date:8/19/2014)... The ancestors of today,s crocodiles colonised the seas during ... to a new Anglo-French study which establishes a link ... temperature over a period of more than 140 million ... Martin from the Universit de Lyon, France and formerly ... week in Nature Communications ., Today, crocodiles are ...
Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Evolution of marine crocodilians constrained by ocean temperatures 2
... age-old tradition that dates back at least 8,000 years ... about the bacteria responsible for turning milk into cheese., ... has identified a new line of bacteria they believe ... cheeses. , The team used DNA fingerprinting techniques to ...
... 6, 2009 Elsevier, a leading global healthcare and ... in the Elsevier Grand Challenge, a competition inviting ... amount of online life sciences information. ( ... on December 15th at the Massachusetts Institute of ...
... 2009, St. Louis, MO As adolescents mature into young adults, ... impact eating habits in a negative way. In a study published ... American Dietetic Association , researchers observed that while young adults enjoy ... 42% of females reported lacking time to sit down and eat ...
Cached Biology News:Wonderful cheese is all in the culture 2Finalists announced in the Elsevier Grand Challenge 2Finalists announced in the Elsevier Grand Challenge 3Young adults need to make more time for healthy meals 2
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Newborn Bovine Serum Heat-Inactivated...
Performance, mycoplasma, virus, and endotoxin tested...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: